The Scientist

» biotech and immunology

Most Recent

image: Microbes Play Role in Anti-Tumor Response

Microbes Play Role in Anti-Tumor Response

By | November 5, 2015

Gut microbiome composition can influence the effectiveness of cancer immunotherapy in mice.

1 Comment

image: Ebola’s Immune Escape

Ebola’s Immune Escape

By | November 3, 2015

The virus can persist in several tissues where the immune system is less active. Researchers are working to better understand this phenomenon and how it can stall the clearing of Ebola in survivors.

1 Comment

image: Fanning the Flames

Fanning the Flames

By | November 1, 2015

Obesity triggers a fatty acid synthesis pathway, which in turn helps drive T cell differentiation and inflammation.

0 Comments

image: Not Immune to Fat

Not Immune to Fat

By | November 1, 2015

The effect of a high-fat diet on murine T cells

0 Comments

image: Weak Support for Malaria Vaccine

Weak Support for Malaria Vaccine

By | October 27, 2015

The World Health Organization recommends more pilot trials.

0 Comments

image: Following FDA OK, 23andMe to Expand Health Prediction

Following FDA OK, 23andMe to Expand Health Prediction

By | October 21, 2015

The personal genomics firm is ramping up its suite of disease-related genetic tests.

0 Comments

image: B Cells Can Drive Inflammation in MS

B Cells Can Drive Inflammation in MS

By | October 21, 2015

Researchers identify a subset of proinflammatory cytokine-producing B cells that may spark multiple sclerosis-related inflammation.  

0 Comments

image: Two-Faced Proteins May Tackle HIV Reservoirs

Two-Faced Proteins May Tackle HIV Reservoirs

By | October 21, 2015

Researchers design antibody-like proteins to awaken and destroy HIV holdouts.

0 Comments

image: Gene-Edited Pets

Gene-Edited Pets

By | October 2, 2015

Genomics giant BGI announces plans to sell “micro-pigs” it originally developed for research.

1 Comment

image: Biotech Stocks Take a Hit

Biotech Stocks Take a Hit

By | September 30, 2015

Some say the biotech bubble has burst over concerns that drug prices are too high—and may soon be regulated.

1 Comment

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech